MaxCyte
Yahoo Finance • last year
MaxCyte Appoints Ali Soleymannezhad as Executive Vice President of Bioprocessing
ROCKVILLE, Md., Sept. 06, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization... Full story
Yahoo Finance • 2 years ago
MaxCyte Reports Fourth Quarter and Full Year 2022 Financial Results
MaxCyte, Inc 31% Total Revenue Growth for Full Year 2022 including 26% Core Business Revenue Growth and $4.6 million in Program-related Revenue ROCKVILLE, Md., March 15, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT),... Full story
Yahoo Finance • 2 years ago
MaxCyte Establishes New Scientific Advisory Board Comprised of Globally Recognized Experts in Cell Engineering Enabling Technology
MaxCyte, Inc MaxCyte’s Scientific Advisory Board will provide guidance to shape the technical direction of the company’s innovation initiatives focused on the discovery, development and manufacturing of next-generation, cell-based medicin... Full story
Yahoo Finance • 2 years ago
Insiders who bought in the last 12 months lose an additional US$55k as MaxCyte, Inc. (LON:MXCT) drops to UK£566m
Insiders who acquired US$166k worth of MaxCyte, Inc.'s (LON:MXCT) stock at an average price of US$8.29 in the past 12 months may be dismayed by the recent 10% price decline. Insiders buy with the expectation to see their investments rise i... Full story
Yahoo Finance • 2 years ago
MaxCyte to Report Third Quarter 2022 Financial Results on November 9, 2022
ROCKVILLE, Md., Oct. 12, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as we... Full story
Yahoo Finance • 2 years ago
Top 10 Stock Picks of Eli Casdin’s Casdin Capital
In this article, we discuss the top 10 stock picks of Eli Casdin's Casdin Capital. If you want to skip our detailed analysis of Casdin's investment philosophy and performance, go directly to Top 5 Stock Picks of Eli Casdin's Casdin Capital... Full story
Yahoo Finance • 2 years ago
MaxCyte to Report Second Quarter 2022 Financial Results on August 10, 2022
GAITHERSBURG, Md., July 15, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as... Full story
Yahoo Finance • 2 years ago
MaxCyte Signs Strategic Platform License with LG Chem to Advance its Allogeneic CAR-T Programs
GAITHERSBURG, Md., July 12, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as... Full story
Yahoo Finance • 3 years ago
MaxCyte to Report First Quarter 2022 Financial Results on May 9, 2022
MaxCyte, Inc GAITHERSBURG, Md., April 20, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-base... Full story
